Sanofi-Aventis (France) Sets Up $200M Biotech Plant, Seeks Partnerships

VITRY-SUR-SEINE, France, May 5 (Reuters) - Sanofi-Aventis (SASY.PA) announced a 200 million euro plan to convert a French factory to biotechnology, highlighting efforts by the world’s fourth largest drugmaker to penetrate the growing sector.